webinar register page

Webinar banner
NeuroNetwork for Emerging Therapies Mini Symposium Series: Complications of COVID-19
Eva L. Feldman, MD, PhD, Director of the NeuroNetwork for Emerging Therapies, will moderate the 30-minute webinar and discuss COVID-19's impact on the brain. Presentations will be made by endocrinologist Rodica Pop-Busui, MD, PhD, who will discuss the effects of COVID-19 on diabetes; cardiologist Salim Hayek, MD, who will talk about how heart health is affected by the disease; and nephrologist Matthias Kretzler, MD, who will speak about drug discovery.

Aug 6, 2020 02:00 PM in Eastern Time (US and Canada)

Eva L. Feldman, MD, PhD
* Required information
Loading

Speakers

Matthias Kretzler, MD
Warner-Lambert/Parke-Davis Professor, Internal Medicine-Nephrology @Michigan Medicine
The overarching goal of Dr. Kretzler's research is to define chronic kidney disease in mechanistic terms and use this knowledge for targeted therapeutic interventions. To reach this goal he and his team have developed a translational research pipeline centered on integrated systems biology analysis of renal disease. Dr. Kretzler has 25 years of experience on interdisciplinary data integration of large-scale data sets in international multi-disciplinary research networks in the United States, Europe, China, and sub-Saharan Africa. These studies enable precision medicine across the genotype-phenotype continuum using carefully monitored environmental exposures, genetic predispositions, transcriptional networks, proteomic profiles, metabolic fingerprints, digital histological biopsy archive and prospective clinical disease characterization. More about Dr. Kretzler: https://medicine.umich.edu/dept/mneuronet/matthias-kretzler-md
Rodica Pop-Busui, MD, PhD
Larry D. Soderquist Professor, Internal Medicine, Metabolism, Endocrinology and Diabetes @Michigan Medicine
Rodica Pop-Busui, MD, PhD, is the Larry D. Soderquist Professor of Diabetes, a prominent diabetologist at Michigan Medicine and a recognized leader in the field of diabetes and diabetes complications. She is the Vice Chair for Clinical Research in the Department of Internal Medicine and the Director of Clinical Research, Mentoring and Development of the M-Diabetes at the University of Michigan. Her research interests involve the chronic complications of diabetes, diabetic peripheral and cardiovascular autonomic neuropathy, nephropathy and cardiovascular disease, and novel technologies for treating type 1 diabetes. Dr. Pop-Busui has published over 170 peer-reviewed manuscripts and book chapters, and received awards from the Fulbright Foundation, the American Diabetes Association (ADA), and the University of Michigan. She has been an elected member of the Clinical Practice Committee of the ADA. More about Dr. Pop-Busui: https://medicine.umich.edu/dept/mneuronet/rodica-pop-busui-md-phd
Salim Hayek, MD
Assistant Professor, Cardiovascular Medicine @Michigan Medicine
Dr. Hayek's research focuses on the study of inflammation as the link between cardiovascular disease and kidney disease. Compared to the rest of the population, patients with chronic kidney disease are dramatically more affected by cardiovascular disease and vice versa. Dr. Hayek's work indicates this is the case across ages, races, and sexes, and doesn't seem to be fully accounted for by risk factors like hypertension and diabetes. His goal is to find the mechanisms behind this cross-over in diseases, and identifying new treatment targets for preventing kidney injury and decrease the risk of heart disease. Additionally, Dr. Hayek is expanding the Michigan Medicine Cardio-Oncology Clinic, where he focuses on the cardiovascular health of cancer patients, extending from prevention to treatment of cardiac side effects of chemotherapy and radiation therapy. More about Dr. Hayek: https://medicine.umich.edu/dept/mneuronet/salim-hayek-md